Call 972-746-2222 Now to Schedule
JEFFREY ADELGLASS, M.D., F.A.C.S.
CLINICAL RESEARCH STUDIES
Dallas | ft. worth TEXAS
currently enrolling subjects for
PAID CLINICAL RESEARCH participation
About the Investigational Vaccine
The NextCOVE Study is testing mRNA-1283.222, one of Moderna's bivalent (addressing multiple viral strains at the same time) COVID-19 investigational vaccines that may protect people from getting sick if they come into contact with the virus that causes COVID-19 and multiple variants, including the Omicron variant. Moderna will be evaluating this investigational vaccine as a booster dose in children and adults to learn more about how it works in the body.
Normally, vaccines for viruses are made from a weakened or inactive (not live) virus, but the mRNA-1283.222 investigational vaccine is different. It is made from messenger RNA (mRNA), an instructional molecule that naturally occurs in the body and tells cells how to make protein. The goal of this vaccine is for the protein to trigger the body's immune system to create the antibodies it needs to fight the real SARS-CoV-2 virus, which causes COVID-19.
You or your child, along with up to 8,471 other individuals, will be helping researchers learn more about Moderna's investigational vaccine that may help protect people from getting sick if they come into contact with the virus that causes COVID-19, including its Omicron variant. You or your child's participation could contribute to a potential solution to the evolving COVID-19 pandemic, which has affected the entire world.
About the NextCOVE Study
The purpose of the NextCOVE Study is to evaluate an investigational bivalent vaccine that may protect people from getting sick if they come into contact with the virus that causes COVID-19 and multiple variants, including the Omicron variant.
You or your child will be chosen at random to receive either the investigational booster dose of mRNA-1283.222 or mRNA-1273.222.
In order to join this clinical trial, you or your child must:
- Be at least 12 years old
- Have received a Covid-19 vaccine
- and at least 1 booster dose of a Covid-19 vaccine
The booster doses are not required for participants younger than 18 years of age. All trial participants will receive medical care from the trial doctor while on the NextCOVE Study.
The trial doctor and trial team will talk to you about additional medical support that you or your child will receive if any COVID-19 symptoms are experienced at any time while in the trial.
Insurance is not needed for you to join this clinical research trial. Compensation may be provided for your time.
To Learn more, visit NextCOVEStudy.com or contact the participating site listed here:
(972) 746-2222
Research Your Health
Jeffrey Adelglass, M.D., F.A.C.S., Principal Investigator
6020 W. Parker Rd., Suite 305, Plano, TX 75093